* MERISTEM THERAPEUTICS *
1997 - Centre
Clermont-Ferrand
www.meristem-therapeutics.com Design, Drugs
(also Discovery, Drugs)
Key words: Therapeutic Proteins, Gene technology, Plants, MABs, Manufacturing, Processing, Third Parties, Merispase, Cystic fibrosis
Mission: to produce therapeutic proteins (e.g., monoclonal antibodies) for third parties needs, with many advantages in comparison to other systems (biological safety, high flexibility, low cost), and to develop own portfolio of innovative therapeutic proteins
Clients: Pharmaceutical industry, Biotechs
meristem@meristem-therapeutics.com
Identity| TYPE/MANAGEMENT/INVESTORS | FINANCES/STATUS | | Start-up |
Managing Dir.: Rohmer (Jean-Paul) [born 1947, Ph.D. Management, Dauphine, ex-Eli Lilly, Stallergènes (CEO)]
Sc.Dir.: Burtin (Daniel) [Ph.D. Biochemistry, ex-INRA]
Oper.Dir.: Boisgard (Catherine) [ex-Human Resources]
Fin.Dir.:
BusDev:
Financers: Limagrain (Unigrains), BNP, Tethys, 3i, Sofipar, Sofimac, AGF P.E., Antin Innovation, CPR P.E., Innoven, Edmond de Rotschild I.P., Odyssée Ventures, Pechel Industrie, SPEF | Turnover (M€) : 0.17 (2006)
Total funding (M€) : n.a.
Last funding (M€) : n.a.
Focus : Multiple
Position : Trade
Company confirm : neutral |
History | DATE | MILESTONE | TYPE | TIME | | 2007 .10 | Court : applications on appeal for GMO corn testing, rejected by tribunal | LEGAL | [10 years] |
| 2004 .02 | Nomination : Jean-Paul Rohmer, chairman of Supervisory Board | ORGN | [7 years] |
| 2002 .06 | 3rd round-financing : 21.5 M€, by AGF P.E., Antin Innovation, CPR P.E., Innoven, Edmond de Rotschild I.P., Odyssée Ventures, Pechel Industrie, SPEF, and previous shareholders | RFINC | [5 years] |
| 2001 .07 | Listing : failure of IPO introduction due to unfavorable financial environment for 54 M€ expected | PBO | [4 years] |
| 2000 .11 | Acquisition of Sedaherb, phyto-subcontractor to pharmaceutical industry, for around 1 year turnover, 3.5 M€ | ACQ+ | [3 years] |
| 2000 .06 | 2nd round-financing : 10.0 M€, by BNP, Tethys, 3i, Sofipar, Sofimac | RFINB | [3 years] |
| 1998 .01 | 1st round-financing : 10.0 M€, by Limagrain | RFINA | [1 year] |
| 1997 .12 | Company founded by Limagrain (Agro Cny., the number one seed producer in Europe), based on an innovative technology (Molecular Pharming) developped since 1992 | ORGF | [0 year] | Actualisation / Updating: 31-Oct-2008 |
|
